Survival Benefit of a Monoclonal Antibody against Cadherin-17 in an Orthotopic Liver Tumor Xenograft Model

References (25)

1. 1 Structure and function of immunoglobulins [DOI]
2. 2 Animal models of disease: Pre-clinical animal models of cancer and their applications and utility in drug discovery [DOI]
3. 3 Antibody humanization methods – a review and update [DOI]
4. 4 Cadherin-17 interacts with α2β1 integrin to regulate cell proliferation and adhesion in colorectal cancer cells causing liver metastasis [DOI]
5. 5 Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma # [DOI]
6. 6 Cadherin-17 is a useful diagnostic marker for adenocarcinomas of the digestive system [DOI]
7. 7 Tissue-Specific Cadherin CDH17 Is a Useful Marker of Gastrointestinal Adenocarcinomas With Higher Sensitivity Than CDX2 [DOI]
8. 8 Blockage of testicular connexins induced apoptosis in rat seminiferous epithelium [DOI]
9. 9 Clinical relevance and therapeutic potential of angiopoietin-like protein 4 in hepatocellular carcinoma [DOI]
10. 10 Role of cadherin-17 in oncogenesis and potential therapeutic implications in hepatocellular carcinoma [DOI]
11. 11 An RGD Motif Present in Cadherin 17 Induces Integrin Activation and Tumor Growth [DOI]
12. 12 Prognostic Marker MicroRNA-125b Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells Via Suppressing Tumorigenic Molecule eIF5A2 [DOI]
13. 13 Targeting Cadherin-17 Inactivates Ras/Raf/MEK/ERK Signaling and Inhibits Cell Proliferation in Gastric Cancer [DOI]
14. 14 Targeting CDH17 Suppresses Tumor Progression in Gastric Cancer by Downregulating Wnt/β-Catenin Signaling [DOI]
15. 15 Lentiviral‐mediated miRNA against liver‐intestine cadherin suppresses tumor growth and invasiveness of human gastric cancer [DOI]
16. 16 Cadherin-17 induces tumorigenesis and lymphatic metastasis in gastric cancer through activation of NFκB signaling pathway [DOI]
17. 17 Comparative proteomic analysis of mouse livers from embryo to adult reveals an association with progression of hepatocellular carcinoma [DOI]
18. 18 Identification of liver–intestine cadherin in hepatocellular carcinoma—a potential disease marker [DOI]
19. 19 Liver‐intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus‐positive hepatocellular carcinoma [DOI]
20. 20 Structure and function of immunoglobulins [DOI]
21. 21 Humanization and Simultaneous Optimization of Monoclonal Antibody [DOI]
22. 22 Involvement of liver-intestine cadherin in cancer progression [DOI]
23. 23 Humanization and Simultaneous Optimization of Monoclonal Antibody [DOI]
24. 24 Blockade of proliferation and migration of gastric cancer via targeting CDH17 with an artificial microRNA [DOI]
25. 25 Expression of ankyrin repeat and SOCS box containing 4 (ASB4) confers migration and invasion properties of hepatocellular carcinoma cells [DOI]

Cited by 6

Showing 3 of 6 known citations — external sources report more than can currently be individually listed.

Related research

• Association of Age and Residual/ Recurrence in First Year after Treatment of Oral Cavity Squamous Cell Carcinoma — shares topic coverage
• Multidrug-Resistant Aeromonas hydrophila in Retail Fish Markets: Prevalence, Survival and Public Health Implications — shares topic coverage
• Compensatory Responses of Cyprinus carpio (Linnaeus, 1758) fry under Different Feed-deprivation Regimes in Happas in the Westhern – Cameroon — shares topic coverage
• Domestication and Survival of Selected Medicinal Trees and Shrubs in Chapereria Division West Pokot County Kenya — shares topic coverage
• Acute and Sub-Lethal Toxic Effects of a Contaminated Dumpsite Soil to the Earthworm, Eisenia fetida (Savigny, 1826) — shares topic coverage